Biotech · Private company · Bozeman, MT, US
Nanovalent Pharmaceuticals, Inc.
Track this companyFree. Adds Nanovalent Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)Fiscal year 2025 · $1MNIH RePORTER 5R42CA281707-03 · fetched Nov 12, 2026
- Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)Fiscal year 2024 · $1MNIH RePORTER 4R42CA281707-02 · fetched Nov 12, 2026